Krystal Biotech, Inc.
KRYS
$306.29
-$10.01-3.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 823.41M | 827.79M | 731.07M | 681.99M | 616.85M |
| Total Receivables | 127.02M | 127.43M | 129.63M | 111.44M | 103.26M |
| Inventory | 42.65M | 40.48M | 37.63M | 31.04M | 29.94M |
| Prepaid Expenses | 26.67M | 28.91M | 27.32M | 16.88M | 16.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.02B | 1.02B | 925.65M | 841.35M | 766.80M |
|
|
|||||
| Total Current Assets | 1.02B | 1.02B | 925.65M | 841.35M | 766.80M |
| Net Property, Plant & Equipment | 160.62M | 158.02M | 156.32M | 158.04M | 158.93M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.12M | 23.11M | 25.01M | 197.00K | 218.00K |
| Total Assets | 1.40B | 1.33B | 1.24B | 1.14B | 1.07B |
|
|
|||||
| Total Accounts Payable | 4.09M | 3.24M | 2.10M | 7.12M | 2.67M |
| Total Accrued Expenses | 84.84M | 81.25M | 74.08M | 66.65M | 59.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.80M | 1.77M | 1.70M | 1.62M | 1.36M |
| Total Finance Division Other Current Liabilities | 17.07M | 16.69M | 13.39M | 11.51M | 16.16M |
| Total Other Current Liabilities | 17.07M | 16.69M | 13.39M | 11.51M | 16.16M |
| Total Current Liabilities | 107.80M | 102.94M | 91.27M | 86.90M | 79.49M |
|
|
|||||
| Total Current Liabilities | 107.80M | 102.94M | 91.27M | 86.90M | 79.49M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.31M | 7.57M | 7.81M | 8.06M | 8.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.12M | 3.72M | 3.14M | 2.79M | 1.95M |
| Total Liabilities | 120.24M | 114.23M | 102.22M | 97.75M | 89.74M |
|
|
|||||
| Common Stock & APIC | 1.20B | 1.19B | 1.16B | 1.15B | 1.13B |
| Retained Earnings | 80.10M | 24.16M | -27.24M | -106.60M | -144.94M |
| Treasury Stock & Other | -1.62M | 1.14M | 1.10M | 1.16M | 390.00K |
| Total Common Equity | 1.28B | 1.22B | 1.14B | 1.04B | 984.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.28B | 1.22B | 1.14B | 1.04B | 984.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.28B | 1.22B | 1.14B | 1.04B | 984.67M |
|
|
|||||